Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 Dec;10(6):603–610. doi: 10.1111/j.1365-2125.1980.tb00516.x

Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan.

A R Green, J K Aronson, G Curzon, H F Woods
PMCID: PMC1430228  PMID: 6162471

Abstract

1 The metabolism of three oral doses of L-tryptophan (50, 25 and 10 mg/kg) in healthy young males has been investigated. 2 There was a linear relationship between both peak and area under curve of the total plasma tryptophan concentrations whilst the relationship between these parameters and plasma free tryptophan was hyperbolic. 3 Before the tryptophan load about 85% of plasma tryptophan was bound to albumin. As plasma tryptophan concentrations increased there was a hyperbolic increase in free tryptophan. Scatchard analysis revealed 1.4 binding sites/molecule albumin with a dissociation constant (Kd) of 57.9 microM. Following administration of L-tryptophan (50 mg/kg) twice daily for 7 days there was no alteration in the number of binding sites but the dissociation constant (Kd) had decreased to 30.9 microM. 4 L-Tryptophan (50 mg/kg twice daily for 7 days) markedly increased both basal plasma total and free tryptophan. However following a further load the total tryptophan curve was comparable to that seen after acute administration. The plasma free tryptophan curve was lowered relative to that seen after an acute dose. 5 Increasing the tryptophan dose shortened the plasma half-life and decreased the volume of distribution and the rate of clearance. Longer term tryptophan administration had no significant effect on plasma half-life or volume of distribution but did decrease the rate of plasma clearance. 6 The plasma kynurenine concentration increased with increasing tryptophan dose and basal concentrations increased markedly after longer term tryptophan administration. 7 Tryptophan administration either acutely or chronically produced little change in urinary tryptophan or 5-hydroxyindole acetic acid excretion. Urinary kynurenine and indole acetic acid excretion increased with increasing doses of tryptophan. 8 Data are discussed in relation to the administration of L-tryptophan for the treatment of depression.

Full text

PDF
603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloxam D. L., Curzon G. A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J Neurochem. 1978 Nov;31(5):1255–1263. doi: 10.1111/j.1471-4159.1978.tb06250.x. [DOI] [PubMed] [Google Scholar]
  2. Bloxam D. L., Hutson P. H., Curzon G. A simple apparatus for ultrafiltration of small volumes: application to the measurement of free and albumin-bound tryptophan in plasma. Anal Biochem. 1977 Nov;83(1):130–142. doi: 10.1016/0003-2697(77)90518-8. [DOI] [PubMed] [Google Scholar]
  3. Bloxam D. L., Tricklebank M. D., Patel A. J., Curzon G. Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain. J Neurochem. 1980 Jan;34(1):43–49. doi: 10.1111/j.1471-4159.1980.tb04619.x. [DOI] [PubMed] [Google Scholar]
  4. Carroll B. J., Mowbray R. M., Davies B. Sequential comparison of L-tryptophan with E.C.T. in severe depression. Lancet. 1970 May 9;1(7654):967–969. doi: 10.1016/s0140-6736(70)91096-2. [DOI] [PubMed] [Google Scholar]
  5. Chouinard G., Young S. N., Annable L., Sourkes T. L. Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study. Acta Psychiatr Scand. 1979 Apr;59(4):395–414. doi: 10.1111/j.1600-0447.1979.tb04482.x. [DOI] [PubMed] [Google Scholar]
  6. Coppen A., Shaw D. M., Herzberg B., Maggs R. Tryptophan in the treatment of depression. Lancet. 1967 Dec 2;2(7527):1178–1180. doi: 10.1016/s0140-6736(67)91894-6. [DOI] [PubMed] [Google Scholar]
  7. Coppen A., Shaw D. M., Malleson A., Eccleston E., Gundy G. Tryptamine metabolism in depression. Br J Psychiatry. 1965 Oct;111(479):993–998. doi: 10.1192/bjp.111.479.993. [DOI] [PubMed] [Google Scholar]
  8. Curzon G., Friedel J., Katamaneni B. D., Greenwood M. H., Lader M. H. Unesterified fatty acids and the binding of tryptophan in human plasma. Clin Sci Mol Med. 1974 Nov;47(5):415–424. doi: 10.1042/cs0470415. [DOI] [PubMed] [Google Scholar]
  9. Curzon G. Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl. 1979;(15):81–92. doi: 10.1007/978-3-7091-2243-3_7. [DOI] [PubMed] [Google Scholar]
  10. Denckla W. D., Dewey H. K. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 1967 Jan;69(1):160–169. [PubMed] [Google Scholar]
  11. Domino E. F., Krause R. R. Plasma tryptophan tolerance curves in drug free normal controls, schizophrenic patients and prisoner volunteers. J Psychiatr Res. 1974 Oct;10(3-4):247–261. doi: 10.1016/0022-3956(74)90008-9. [DOI] [PubMed] [Google Scholar]
  12. Grahame-Smith D. G. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem. 1971 Jun;18(6):1053–1066. doi: 10.1111/j.1471-4159.1971.tb12034.x. [DOI] [PubMed] [Google Scholar]
  13. Green A. R., Aronson J. K., Curzon G., Woods H. F. Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. Br J Clin Pharmacol. 1980 Dec;10(6):611–615. doi: 10.1111/j.1365-2125.1980.tb00517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Green A. R., Bloomfield M. R., Woods H. F., Seed M. Metabolism of an oral tryptophan load by women and evidence against the induction of tryptophan pyrrolase by oral contraceptives. Br J Clin Pharmacol. 1978 Mar;5(3):233–241. doi: 10.1111/j.1365-2125.1978.tb01630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Green A. R., Curzon G. Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature. 1968 Dec 14;220(5172):1095–1097. doi: 10.1038/2201095a0. [DOI] [PubMed] [Google Scholar]
  16. Green A. R., Curzon G. The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem Pharmacol. 1970 Jun;19(6):2061–2068. doi: 10.1016/0006-2952(70)90303-5. [DOI] [PubMed] [Google Scholar]
  17. Green A. R., Sourkes T. L., Young S. N. Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils. Br J Pharmacol. 1975 Feb;53(2):287–292. doi: 10.1111/j.1476-5381.1975.tb07360.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Green A. R. The effects of dietary tryptophan and its peripheral metabolism on brain-5-hydroxytryptamine synthesis and function. Essays Neurochem Neuropharmacol. 1978;3:103–127. [PubMed] [Google Scholar]
  19. Green A. R., Woods H. F., Knott P. G., Curzon G. Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature. 1975 May 8;255(5504):170–170. doi: 10.1038/255170a0. [DOI] [PubMed] [Google Scholar]
  20. Green H., Sawyer J. L. Demonstration, characterization, and assay procedure of tryptophan hydroxylase in rat brain. Anal Biochem. 1966 Apr;15(1):53–64. doi: 10.1016/0003-2697(66)90247-8. [DOI] [PubMed] [Google Scholar]
  21. Gál E. M., Young R. B., Sherman A. D. Tryptophan loading: consequent effects on the synthesis of kynurenine and 5-hydroxyindoles in rat brain. J Neurochem. 1978 Jul;31(1):237–244. doi: 10.1111/j.1471-4159.1978.tb12454.x. [DOI] [PubMed] [Google Scholar]
  22. Jensen K., Fruensgaard K., Ahlfors U. G., Pihkanen T. A., Tuomikoski S., Ose E., Dencker S. J., Lindberg D., Nagy A. Letter: Tryptophan/imipramine in depression. Lancet. 1975 Nov 8;2(7941):920–920. doi: 10.1016/s0140-6736(75)92151-0. [DOI] [PubMed] [Google Scholar]
  23. Joseph M. H., Risby D. The determination of kynurenine in plasma. Clin Chim Acta. 1975 Sep 1;63(2):197–204. doi: 10.1016/0009-8981(75)90163-1. [DOI] [PubMed] [Google Scholar]
  24. KNOX W. E., AUERBACH V. H. The hormonal control of tryptophan peroxidase in the rat. J Biol Chem. 1955 May;214(1):307–313. [PubMed] [Google Scholar]
  25. Kiely M., Sourkes T. L. Transport of L-tryptophan into slices of rat cerebral cortex. J Neurochem. 1972 Dec;19(12):2863–2872. doi: 10.1111/j.1471-4159.1972.tb03824.x. [DOI] [PubMed] [Google Scholar]
  26. Mans A. M., Biebuyck J. F., Saunders S. J., Kirsch R. E., Hawkins R. A. Tryptophan transport across the blood-brain barrier during acute hepatic failure. J Neurochem. 1979 Aug;33(2):409–418. doi: 10.1111/j.1471-4159.1979.tb05170.x. [DOI] [PubMed] [Google Scholar]
  27. McMENAMY R. H., ONCLEY J. L. The specific binding of L-tryptophan to serum albumin. J Biol Chem. 1958 Dec;233(6):1436–1447. [PubMed] [Google Scholar]
  28. Moir A. T., Eccleston D. The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J Neurochem. 1968 Oct;15(10):1093–1108. doi: 10.1111/j.1471-4159.1968.tb06827.x. [DOI] [PubMed] [Google Scholar]
  29. Murphy D. L., Baker M., Goodwin F. K., Miller H., Kotin J., Bunney W. E., Jr L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia. 1974 Jan 9;34(1):11–20. doi: 10.1007/BF00421216. [DOI] [PubMed] [Google Scholar]
  30. Nomura M., Colmenares J. L., Wurtman R. J. Effect of dietary protein on urinary 5-hydroxyindoleacetic acid levels. J Neurochem. 1977 Aug;29(2):267–271. doi: 10.1111/j.1471-4159.1977.tb09618.x. [DOI] [PubMed] [Google Scholar]
  31. Singleton C., Marsden C. A. Increased responsiveness to 5-methoxy-N,N-dimethyltryptamine in mice on a high tryptophan diet. Neuropharmacology. 1979 Jun;18(6):569–572. doi: 10.1016/0028-3908(79)90103-5. [DOI] [PubMed] [Google Scholar]
  32. UDENFRIEND S., WEISSBACH H., BRODIE B. B. Assay of serotonin and related metabolites, enzymes, and drugs. Methods Biochem Anal. 1958;6:95–130. doi: 10.1002/9780470110225.ch5. [DOI] [PubMed] [Google Scholar]
  33. d'Elia G., Hanson L., Raotma H. L-tryptophan and 5-hydroxytryptophan in the treatment of depression. A review. Acta Psychiatr Scand. 1978 Mar;57(3):239–252. doi: 10.1111/j.1600-0447.1978.tb06890.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES